Pub. Date : 2020 May
PMID : 32366411
3 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Antitumor Effects of Pan-RAF Inhibitor LY3009120 Against Lung Cancer Cells Harboring Oncogenic BRAF Mutation. | LY3009120 | B-Raf proto-oncogene, serine/threonine kinase | Homo sapiens |
| 2 | LY3009120, a newly discovered pan-RAF inhibitor, has shown strong antitumor effects in cancers with various BRAF genotypes. | LY3009120 | B-Raf proto-oncogene, serine/threonine kinase | Homo sapiens |
| 3 | CONCLUSION: LY3009120 is a potent therapeutic agent for patients with BRAF non-V600E mutant NSCLC. | LY3009120 | B-Raf proto-oncogene, serine/threonine kinase | Homo sapiens |